Abstract:Objective To study C-X3-C chemokine ligand 1 (CX3CL1) in plasma or cerebrospinal fluid whether could be used as an biomaker of central nervous system infection.Methods The plasma and CSF samples were collected from neonates who were suspected to have central nervous infection with lumbar puncture check admitted to Neonatal Ward of Children's Hospital of Fudan University from December 2015 to May 2016,and they set for infection group,according to clinical manifestations,cerebrospinal fluid routine,biochemistry and culture results,they were divided into the central infection,sepsis and non-sepsis groups.At the same period healthy newborns cord blood samples were collected in the maternity ward of Obstetrics and Gynecology Hospital of Fudan University as a normal control group,and on the basis of birth weight group was divided into ＜ 2 000 g,-2 500 g,-3 000 g,-3 500 g,＞3 500 g groups;and according to gestational age divided into ＜ 33 w,-35 w,-37 w,-39 w,＞39 w groups.Using Luminex technology to detect CX3CL1 protein levels (Milliplex reagent kit HCYTOMAG-60K-06),the differences between groups and subgroups were compared.Results In 69 cases of control group,there were 24 cases wit hinfection.There were 8 cases in central infection group (meningitis),10 cases in sepsis group and 6 cases in non-sepsis subgroup (1 case with urinary tract infection,2 cases with neonatal convulsion,1 case with hyperbilirubinemia and esophageal tracheal fistula).In the control group,CX3CL1 in cord blood was (97.8+.13.3) pg · mL-1,there was no significant difference in cord blood CX3CL1 level among different body weight subgroups and different gestational weeks subgroups (P＞0.05).In infection group plasma CX3CL1 level [(95.1±8.2)pg · mL-1] had no significant difference from control group(t=-1.045,P=0.299).There was significant difference in CX3CL1 level between plasma and cerebrospinal fluid,CX3CL1 level was significantly higher in cerebrospinal fluid(210.0 ± 11.9) pg · mL-1 (P ＜ 0.001).Among central infection group,sepsis group and non-sepsis group cerebrospinal fluid CX3CL1 levels (243.1 ± 13.3) pg · mL-1,(208.2 ± 20.1) pg · mL-1 and (168.7 ± 20.6) pg · mL-1,there were significant differences (P=0.046);There were also significant differences in CX3CL1 levels in cerebrospinal fluid between central infection group and non-sepsis group (P =0.016);There were no significant differences in CX3CL1 levels in cerebrospinal fluid between central infection group and sepsis group (P =0.180) or between sepsis group and non-sepsis group (P =0.169).Conclus1on CX3CL1 level in plasma is relatively stable in the healthy newborns,CX3CL1 level in plasma can not be used to diagnose central nervous infection,CSF CX3CL1 levels may be an auxiliary biomarker for diagnosis of central nervous infection and its severity.

Clinical Significance of Cerebrospinal Fluid VEGF in Neonatal Bacterial Meningitis

Cerebrospinal Fluid Proteomics in Meningitis Patients with Reactivated Varicella Zoster Virus

Expression and Biologic Significance of Vascular Endothelial Growth Factor (VEGF) in Human Meningiomas

Significance of Cerebrospinal Fluid Lactate Level in Diagnosing Neonatal Bacterial Meningitis

Expression and significance of vascuIar endothelial growth factor and VIII-R Ag in human brain glioma

Expression of Vascular Endothelial Growth Factor in Human Meningiomas and Peritumoral Brain Areas

Clinical Significance of Mild Fetal Ventriculomegaly by Prenatal Ultrasonography Examination

Clinical characteristic analysis for invasive fungal infection in neonatal intensive care unit

Change of Activin A in Cerebrospinal Fluid of Neonates with Bacterial Meningitis and Its Value for Prognosis Evaluation

Role of Vascular Endothelial Growth Factor in Children's Hydrocephalus

Vascular Endothelial Growth Factor and Matrix Metalloprotease in Lymphomatous Meningitis

Expression and clinical significance of NSE and IGF-Ⅰ in cerebrospinal fluid of pediatric patients with central system infections

Elevated levels of β2-microglobulin in cerebrospinal fluid in adult patients with viral encephalitis/meningitis

[Vascular endothelial factor of meningomas and peritumoural vasogenic brain edema]

Study on the correlation between CX3CL1 and neonatal central nervous system infection

Correlation between Vascular Endothelial Growth Factor and Peritumoral Edema in Meningiomas

Quantitative proteomics on the cerebrospinal fluid of hydrocephalus in neonatal bacterial meningitis

Clinical Significance of Neuron Specific Enolase and S100 Beta Protein in Intracranial Infection and Brain Injury.

The Clinical Significance of Vascular Endothelial Growth Factor with Acute Cerebral Infarction

Role of beta-2-microglobulin as a biomarker in very preterm and extremely preterm infants with CNS inflammation

The Influence of Gestational Age and Postnatal Age on Neonatal Cerebrospinal Fluid Parameters